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The physiological consequences of aberrant Ca2+ binding and exchange with cardiac
myofilaments are not clearly understood. In order to examine the effect of decreasing
Ca2+ sensitivity of cTnC on cardiac function, we generated knock-in mice carrying a
D73N mutation (not known to be associated with heart disease in human patients) in
cTnC. The D73N mutation was engineered into the regulatory N-domain of cTnC in
order to reduce Ca2+ sensitivity of reconstituted thin filaments by increasing the rate of
Ca2+ dissociation. In addition, the D73N mutation drastically blunted the extent of Ca2+
desensitization of reconstituted thin filaments induced by cTnI pseudo-phosphorylation.
Compared to wild-type mice, heterozygous knock-in mice carrying the D73N mutation
exhibited a substantially decreased Ca2+ sensitivity of force development in skinned
ventricular trabeculae. Kaplan-Meier survival analysis revealed that median survival time
for knock-in mice was 12 weeks. Echocardiographic analysis revealed that knock-in mice
exhibited increased left ventricular dimensions with thinner walls. Echocardiographic
analysis also revealed that measures of systolic function, such as ejection fraction
(EF) and fractional shortening (FS), were dramatically reduced in knock-in mice. In
addition, knock-in mice displayed electrophysiological abnormalities, namely prolonged
QRS and QT intervals. Furthermore, ventricular myocytes isolated from knock-in mice
did not respond to β-adrenergic stimulation. Thus, knock-in mice developed pathological
features similar to those observed in human patients with dilated cardiomyopathy (DCM).
In conclusion, our results suggest that decreasing Ca2+ sensitivity of the regulatory
N-domain of cTnC is sufficient to trigger the development of DCM.
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Introduction
Dilated cardiomyopathy (DCM) is a progressive disease of the myocardium characterized by
dilation and impaired systolic function of left or both ventricles (for review Wexler et al., 2009;
Jefferies and Towbin, 2010). DCM frequently progresses to heart failure, and can result in sudden
cardiac death. While DCM can be caused by a variety of factors, mutations in over 40 genes
account for ∼25–30% of cases (for review Towbin, 2014; McNally et al., 2015). Most of the genetic
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cases of DCM are inherited in an autosomal dominant pattern.
An estimated 35–40% of genetic DCM cases are linked to
mutations in genes encoding sarcomeric proteins, including all
three subunits of the cardiac troponin (cTn) complex (for review
Chang and Potter, 2005; McNally et al., 2015). Understanding
how these mutations trigger pathogenesis of DCM is lacking,
although DCM-linked mutations of sarcomeric proteins tend
to desensitize myofilaments to Ca2+ (for review Kimura, 2010;
Willott et al., 2010; Lu et al., 2013; Spudich, 2014).
The heterotrimeric cTn complex, consisting of cardiac
troponin C (cTnC), cardiac troponin I (cTnI) and cardiac
troponin T (cTnT), plays a key role in the regulation of muscle
contractility (for review Farah and Reinach, 1995; Filatov et al.,
1999; Parmacek and Solaro, 2004). cTnC, the Ca2+ sensing
subunit of the cTn complex, consists of the N- and C-terminal
globular domains linked by a central α-helix. Each globular
domain contains a pair of EF-hand (29 residue helix-loop-
helix) Ca2+ binding motifs, numbered I–IV. A canonical EF-
hand motif consists of a 12 residue loop flanked by two α-
helices (for review Nelson and Chazin, 1998). Coordination
of Ca2+ involves six residues located in chelating positions
1(+X), 3 (+Y), 5 (+Z), 7 (−Y), 9 (−X), and 12 (−Z) of the
loop. Due to inability of the first EF-hand to bind Ca2+, the
second EF-hand controls Ca2+ binding and exchange with the
regulatory N-domain of cTnC. The ability of cTnC to sense
and respond to changes in intracellular Ca2+ is modulated by
the othermyofilament proteins.Mutations and post-translational
modifications of myofilament proteins, linked to diseases of the
myocardium, can result in an abnormal response of cTnC to
Ca2+ (for review Davis and Tikunova, 2008).
CTnI, the inhibitory subunit of the cTn complex, transmits
Ca2+ signal from cTnC to other components of the myofilaments
(for review Farah and Reinach, 1995; Filatov et al., 1999;
Parmacek and Solaro, 2004). Phosphorylation of cTnI by protein
kinase A (PKA) on Ser22/23 residues, which occurs during β-
adrenergic stimulation, desensitizes myofilaments to Ca2+ by
accelerating the rate of Ca2+ dissociation from the regulatory
N-domain of cTnC (for review Solaro et al., 2008; Solaro and
Kobayashi, 2011; Solaro et al., 2013). Recent studies showed
that a number of mutations in myofilament proteins, linked to
cardiomyopathies, blunt or abolish the Ca2+ desensitizing effect
of cTnI phosphorylation on Ser22/23 residues (for review Messer
and Marston, 2014). Blunting the extent of Ca2+ desensitization
induced by cTnI phosphorylation appears to be a common
feature among DCM-linked mutations (for review Messer and
Marston, 2014; Kalyva et al., 2014).
The overriding goal of our work is to gain a deeper insight
into physiological consequences of altering Ca2+ binding and
exchange with cardiac myofilaments. The objective of this work
was to determine whether decreasing Ca2+ sensitivity of the
regulatory N-domain of cTnC triggers the pathogenesis of DCM.
To achieve this objective, we engineered a Ca2+ desensitizing
mutation, not known to be associated with DCM in humans, into
the regulatory N-domain of cTnC, and knocked this mutation
into the mouse endogenous TNNC1 gene via gene targeting
technology. Our results show that knock-inmice expressing Ca2+
desensitizing mutant of cTnC develop the phenotype of early
onset DCM.
Materials and Methods
Protein Mutagenesis and Purification
The cTnCD73N and cTnIS22D/S23D mutants were generated as
previously described and verified by DNA sequencing (Tikunova
et al., 2010). The cTn complex subunits were expressed, purified,
and quantified as previously described (Albury et al., 2012;
Swindle et al., 2014). Rabbit fast skeletal actin and bovine cTm
were a generous gift from Dr. Darl Swartz (Delaware Valley
College, Doylestown, PA).
Fluorescent Labeling of cTnC and cTnCD73N
The cTnC construct used to reconstitute the cTn complexes or
thin filaments contained C35S, T53C, and C84S substitutions,
to allow fluorescent labeling of cTnC at Cys53. CTnC and its
mutant were labeled with the environmentally sensitive thiol-
reactive probe IAANS at Cys53 as previously described (Davis
et al., 2007).
Reconstitution of the cTn Complexes and Thin
Filaments
The cTn complexes and thin filaments were prepared and
reconstituted as previously described (Albury et al., 2012; Swindle
et al., 2014).
Determination of Ca2+ Binding Sensitivities and
Dissociation Kinetics
Steady-state fluorescence measurements were carried out using
a Perkin-Elmer LS55 fluorescence spectrometer at 15◦C, as
previously described (Albury et al., 2012; Swindle et al., 2014).
Data were fit with a logistic sigmoid function mathematically
equivalent to the Hill equation. Data represent a mean of at least
three titrations ± S.E. All kinetic measurements were performed
using an Applied Photophysics Ltd. (Leatherhead, UK) model
SX.18MV stopped-flow instrument with a dead time of ∼1.4ms
at 15◦C, as previously described (Albury et al., 2012; Swindle
et al., 2014). Data represent an average of at least three separate
experiments ± S.E., each averaging at least five traces fit with a
single exponential equation.
Generation of Knock-in Mouse Model
The Gene Targeting Mouse Service Core at the University
of Cincinnati (Cincinnati, OH) generated the targeting vector
and the knock-in mice. Mice were backcrossed into C57BL/6J
background using Speed Congenic Service offered by the Jackson
Laboratory (Bar Harbor, ME). The Institutional Animal Care
and Use Committee (IACUC) approved all animal studies.
Male mice, between 4 and 12 week old, were used in all
experiments.
Trabecula Force vs. pCa Measurements
Mice were euthanized by CO2 inhalation, followed by rapid
cardiectomy, in accordance with an Ohio State University
IACUC-approved protocol. The heart was placed in cold relaxing
solution and swirled to remove blood from the chambers. All
of the solutions were as previously described (Reiser et al.,
2013). A single cut was made across the free wall of both
ventricles and each heart was placed individually in a 30ml
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plastic bottle containing glycerinating solution for storage at
−20◦C (1–4 weeks for both genotypes). Each day, on which
force measurements were conducted, a heart was removed
from glycerinating solution and was transferred to cold relaxing
solution with 1% (v/v) Triton X-100. The heart was kept in this
solution for 30–40min on ice, with occasional gentle swirling.
The heart was then transferred to a Sylgard-lined Petri dish
containing relaxing solution and a single trabecula was isolated
by dissection from either the right or left ventricle and mounted
in the experimental chamber, as previously described (Reiser
et al., 2013). Half of the trabeculae were from each ventricle for
both genotypes. The trabecula was set to a length that was just
beyond slack length and the trabecula was imaged using a digital
camera. Resting sarcomere length was measured, with image
analysis software, in a subset (three per each genotype) of the
trabeculae in which a clear striation pattern could be observed.
The length spanning a series of ∼20 striations was measured.
The sarcomere length in these trabeculae [2.18 ± 0.05µm for
WT mice vs. 2.2 ± 0.2µm for heterozygous knock-in mice
(termed D73N(+/−) mice)] did not differ significantly between
genotypes. The width and depth of each trabecula were measured
as previously described (Reiser et al., 2013). Cross-sectional
area was calculated from the width and depth measurements,
assuming an ellipsoidal cross-section. The trabecula was exposed
to series of pCa (-log [Ca2+]) solutions, with complete relaxation
(in pCa 9.0 solution) between each activation. Resting force was
measured (in pCa 9.0 solution) and was subtracted from the total
peak force during each activation to calculate peak active force.
Every third activation was performed with pCa 4.0 solution and
the force in that solution was used to normalize the force during
each temporally neighboring submaximal activation. All force
measurements were made at 15◦C. There was a small decrement
in force generating ability during the course of the measurements
in each trabecula. This was quantitated by calculating the ratio
of the force in the final activation with pCa 4.0 by the force
generated in the initial activation with the same pCa. This ratio
[0.88± 0.02 for WT mice vs. 0.94± 0.04 for D73N (+/−) mice]
did not differ significantly between genotypes.
Heart Weight to Body Weight Analysis
Mice were weighed and anesthetized with 2% isoflurane. Whole
hearts were excised, rinsed with phosphate buffered saline to
remove blood, blotted dry, and weighed.
Histological Analysis
Hearts were excised from anesthetized mice, and fixed in 10%
buffered formalin. Paraffin-embedded longitudinal sections of
whole mouse hearts were prepared and stained with hematoxylin
and eosin (H&E) or Masson’s trichrome by American HistoLabs,
Inc (Gaithersburg,MD). In order to calculate myocardial fibrosis,
the bright field images of longitudinal heart sections stained
with Masson’s trichrome were taken with Nikon Eclipse Ti. The
fibrosis areas (blue) were measured by Image-Pro Plus software
[Media Cybernetics, Inc. (Rockville, MD)]. The percentage of
total fibrosis in each heart was calculated as the sum of blue
stained areas divided by the whole ventricular area. Cross-
sectional area of ventricular myocytes was measured from
the images of H&E stained longitudinal heart sections using
ImageJ software [NIH (Bethesda, MD)]. Data were obtained by
measuring cross-sectional areas of at least 100 nucleated left
ventricular myocytes per heart.
Genotyping
Mouse genomic DNA was isolated from tail biopsies using
Wizard SV Genomic DNA Purification Kit [Promega (Madison,
WI)], according to manufacturer’s instructions. Fragments of
mouse genomic DNA were amplified by a PCR assay (termed P1,
P2, P3 assay) using P1 (5′- AGGACTTGCTTGGCTTCTGAC),
P2 (5′- AGGGTGTCTACCCGAAACTAC), P3 (5′-
CTGCCATAGCCACTCGAGAAG) primer mix. The P1,
P2, P3 assay was used to identify WT, heterozygous neo (+/−),
heterozygous D73N (+/−), and homozygous D73N (+/+)
mice. Product lengths were 384, 287, and 517 base pairs for WT,
neo, and the D73N alleles, respectively.
RT-PCR Analysis
Total RNA was extracted from the left ventricular mouse
tissues using an RNeasy Fibrous Tissue Mini Kit [QIAGEN
(Venlo, Limburg)] according to the manufacturer’s instructions.
Fragments of cDNA were amplified from total RNA using
Superscript III One Step RT PCR system [Invitrogen (Carlsbad,
CA)], according to manufacturer’s instruction. Ratio of the
cTnCD73N mutant to total cTnC in the D73N (+/−) mice was
estimated by RT-PCR using TNNC1 sequence-specific primers
to amplify a 349 bp region of DNA from total RNA isolated from
the left ventricle of D73N (+/−) mice. The RT-PCR product was
digested by the restriction enzyme KpnI. Densitometric analysis
of RT-PCR gel image was performed using ImageJ software. The
densities of the amplicon band before and after digestion with
KpnI were used to calculate the fraction of cTnCD73N in the
D73N (+/−) mice. Sequences of primer sets used to amplify
fragments of cDNA for cTnC, β-MHC (β-myosin heavy chain),
α-MHC (α-myosin heavy chain), and GAPDH (glyceraldehyde-
3-phosphate dehydrogenase) are available upon request.
SDS-PAGE Analysis
Left ventricular free wall samples were isolated by dissection
and were prepared for analysis by SDS-PAGE. The protocols for
sample preparation, gel preparation and running, gel staining,
and densitometric scanning were as previously described (Reiser
and Moravec, 2014). The relative amount of β-MHC [% of total
MHC (α-MHC+ β-MHC)] in each sample was determined from
densitometric scans.
Western Blot Analysis
Western blots were carried out as previously described
(McConnell et al., 2009; Guillory et al., 2013). Briefly, left
ventricles were dissected and flash frozen in liquid nitrogen.
Proteins from left ventricular mouse tissue homogenates were
separated by the SDS-PAGE gradient (4–12% Bis-Tris) gels,
followed by immunoblotting. Primary antibodies against cTnI,
cTnIphospho, GAPDH, and secondary antibody were purchased
fromCell Signaling Technology (Beverly, MA). Primary antibody
against cTnC was purchased from Abcam (Cambridge, England).
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Densitometric analysis of immunoblots was performed using
ImageJ software.
Echocardiography
Echocardiographic studies on mice anesthetized with 1%
isoflurane were performed in the Mouse Phenotyping Core
(Baylor University College of Medicine, Houston, TX) using
VisualSonics Vevo 770 High-Resolution In Vivo Micro-Imaging
System equipped with a 30MHz microprobe (VisualSonics
Inc.,Toronto, Ontario, Canada) as previously described (Guillory
et al., 2013).
Electrocardiography
Electrocardiographic (ECG) signals from mice anesthetized
with 2% isoflurane were acquired and analyzed using Power
Lab System with LabChart software (ADInstruments, Colorado
Springs, CO). ECGs were recorded using subcutaneously inserted
needle electrodes.
Isolation of Mouse Ventricular Myocytes
Adult mouse ventricular myocytes were isolated following a
previously described protocol (Liao and Jain, 2007). Intracellular
Ca2+ and contractility were measured at 37◦C in isolated
myocytes loaded with Fura 2-AM in the absence or presence
of isoproterenol (ISO) (1µmol/L) using an IonOptix system
(Milton, MA), as previously described (Guillory et al., 2013).
Myocytes were paced at 1Hz with IonOptix MyoPacer Field
stimulator (pulse duration 1ms; 5 volts). Data were analyzed
using IonWizard (IonOptix) software.
Statistical Analysis
Statistical significance was determined by an unpaired two-
sample t-test using the statistical analysis software Minitab (State
College, PA). The two means were considered to be significantly
different when the p-value was <0.05. All data are reported as
mean value± S.E. Kaplan-Meier survival curves (for review Rich
et al., 2010) were analyzed by the log-rank test using GraphPad
Prism software (La Jolla, CA).
Results
Effect of the D73N Mutation on the Ca2+
Sensitivity and the Rate of Ca2+ Dissociation
from Reconstituted Thin Filaments in the
Absence and Presence of cTnI
Pseudo-phosphorylation
Previously, we demonstrated that Ca2+ binding and exchange
with an EF-hand within a Ca2+ binding protein can be altered
by mutations of the chelating loop residues (Black et al., 2000;
Liu et al., 2012a). Based on the earlier studies (Black et al.,
2000; Liu et al., 2012a), the D73N mutation (substitution of
an acidic Asp in the -X position of the second Ca2+ binding
loop with neutral Asn) was engineered into cTnC in order to
desensitize the regulatory N-domain of cTnC to Ca2+. The
Ca2+ induced increases in IAANS fluorescence, occurring when
Ca2+ binds to thin filaments reconstituted with the cTn or
cTnD73N complex, are shown in Figure 1A and are summarized
in Table 1. Thin filaments reconstituted with the cTn complex
exhibited a half-maximal Ca2+ dependent increase in IAANS
fluorescence with a pCa50 of 5.45 ± 0.06. The D73N mutation
led to substantial Ca2+ desensitization of reconstituted thin
filaments (1pCa50 = −0.55), without affecting Ca
2+ binding
cooperativity (as indicated by the Hill coefficient nH).
Figure 1A also shows the Ca2+ induced increases in IAANS
fluorescence that occur when Ca2+ binds to thin filaments
FIGURE 1 | Effect of the D73N mutation on the Ca2+ sensitivity and
the rate of Ca2+ dissociation from reconstituted thin filaments in the
absence and presence of cTnI pseudo-phosphorylation. (A) Increases
in IAANS fluorescence, which occur as Ca2+ binds to the regulatory
N-domain of the cTn complex, containing cTnI () or cTnIS22D/S23D (),
reconstituted into thin filaments; and to the regulatory N-domain of the
cTnD73N complex, containing cTnI (◦) or cTnIS22D/S23D (•), reconstituted
into thin filaments. Data represent the mean ± S.E. of at least three titrations
fit with logistic sigmoid function. IAANS fluorescence was excited at 330 nm
and monitored at 450 nm. (B) Time course of decreases in IAANS
fluorescence as Ca2+ was removed by excess EGTA from the regulatory
N-domain of the cTn complex, containing cTnI or cTnIS22D/S23D,
reconstituted into thin filaments; and from the regulatory N-domain of the
cTnD73N complex, containing cTnI or cTnIS22D/S23D, reconstituted into thin
filaments. The data traces have been normalized and staggered for clarity.
Each trace is an average of at least five traces fit with single exponential
equation. The IAANS fluorescence was excited at 330 nm and monitored
through a 510 nm bandpass filter.
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TABLE 1 | Effect of the D73N mutation on the Ca2+ sensitivity and the rate
of Ca2+ dissociation from reconstituted thin filaments in the absence and
presence of cTnI pseudo-phosphorylation.
Parameter cTn cTn (with cTnD73N cTnD73N (with
cTnIS22D/S23D) cTnIS22D/S23D)
pCa50 5.45± 0.06 5.06±0.03
† 4.90± 0.05* 4.78± 0.06‡6=
nH 1.45± 0.5 1.6±0.1 1.68± 0.08 2.2± 0.8
‡#6=
Ca2+ koff (s
−1) 103± 2 320±6† 341± 16* 397± 14‡#6=
All values are expressed as mean ± S.E. for at least three experiments per
group. *cTnD73N values significantly different from their respective cTn values; † cTn
(with cTnIS22D/S23D) values significantly different from their respective cTn values;
‡cTnD73N (with cTnIS22D/S23D) values significantly different from their respective cTn
(with cTnIS22D/S23D) values;#cTnD73N (with cTnIS22D/S23D) values significantly different
from their respective cTnD73N values; 6=cTnD73N (with cTnIS22D/S23D) values significantly
different from their respective cTn values. The p-value < 0.05 was considered statistically
significant.
reconstituted with the cTn or cTnD73N complex, containing
the phosphomimetic of cTnI (cTnIS22D/S23D). Thin filaments
reconstituted with the cTn complex, containing cTnIS22D/S23D,
exhibited a half-maximal Ca2+ dependent increase in IAANS
fluorescence with a pCa50 of 5.06 ± 0.03. In the presence
of cTnI pseudo-phosphorylation, the D73N mutation still
led to Ca2+ desensitization of reconstituted thin filaments
(1pCa50 = −0.28).
Our results indicate that replacement of cTnI by the
phosphomimetic of cTnI resulted in a substantial Ca2+
desensitization (1pCa50 = −0.39) of thin filaments
reconstituted with the cTn complex. However, replacement
of cTnI by the phosphomimetic of cTnI resulted in only minor
Ca2+ desensitization (1pCa50 = −0.12) of thin filaments
reconstituted with the cTnD73N complex. Thus, our results
indicate that the D73N mutation drastically blunted the extent
of Ca2+ desensitization (of thin filaments reconstituted with the
cTnD73N complex) induced by cTnI pseudo-phosphorylation.
Fluorescence stopped-flow measurements, utilizing IAANS
fluorescence, were conducted to determine the effect of the
D73N mutation in cTnC on the rate of Ca2+ dissociation from
the regulatory N-domain of the cTn complex reconstituted
into thin filaments in the absence and presence of cTnI
pseudo-phosphorylation. The results are summarized in Table 1.
Figure 1B shows that Ca2+ was removed (by excess EGTA)
from thin filaments reconstituted with the cTn or cTnD73N
complex at a rate of 103 ± 2, or 341 ± 16 s−1. Thus, the D73N
mutation led to a substantial ∼3.3-fold increase in the rate of
Ca2+ dissociation from thin filaments reconstituted with the
cTn complex. Figure 1B also shows that Ca2+ was removed (by
excess EGTA) from thin filaments reconstituted with the cTn or
cTnD73N complex, containing phosphomimetic of cTnI, at a rate
of 320± 6, or 397± 14 s−1. Thus, in the presence of cTnI pseudo-
phosphorylation, the D73Nmutation led to only∼1.2-fold faster
rate of Ca2+ dissociation from reconstituted thin filaments.
Our results indicate that replacement of cTnI by the
phosphomimetic of cTnI led to ∼3.1-fold increase in the rate
of Ca2+ dissociation from thin filaments reconstituted with the
cTn complex. On the other hand, replacement of cTnI by the
phosphomimetic of cTnI led to only ∼1.2-fold increase in the
rate of Ca2+ dissociation from thin filaments reconstituted with
the cTnD73N complex. Thus, our results indicate that the D73N
mutation blunted the effect of cTnI pseudo-phosphorylation on
the rate of Ca2+ dissociation from thin filaments reconstituted
with the cTnD73N complex.
Generation of Knock-in Mice
Due to its Ca2+ desensitizing properties, the D73N mutation
in cTnC was selected for the introduction into the TNNC1
gene. Figure 2A illustrates the gene targeting strategy used to
change the GAC codon to an AAC codon in exon 4 of the
TNNC1 gene, which corresponds to the D73N mutation in
cTnC. In addition to the D73N mutation, the targeting vector
harbored two silent substitutions in exon 4 in order to generate
a restriction site for the enzyme KpnI. The targeting vector
also harbored a floxed neomycin (neo) resistance cassette in
intron 4. Linearized targeting vector was injected into 129SvEv
ES cells by electroporation. Two ES cell clones, which integrated
the construct by homologous recombination, were identified by
PCR and confirmed by Southern blotting (data not shown).
Properly targeted ES cell clones were injected into C57BL/6
recipient blastocysts to produce chimeras. Male chimeras were
crossed with C57BL/6J females to obtain heterozygous mice with
one allele carrying the D73N mutation and the neo cassette,
termed neo (+/−) mice. The neo (+/−) mice were crossed
with FLP deleter mice, in order to remove the neo cassette,
resulting in heterozygous mice (with the FLP transgene) carrying
the D73N mutation in cTnC. Subsequent round of breeding
with the C57BL/6J mice removed the FLP transgene, generating
heterozygous mice carrying the D73Nmutation in cTnC, termed
D73N (+/−) mice. Removal of the neo cassette was confirmed
by PCR (Figure 2B).
Genotyping of the D73N (+/−) mice and their WT
littermates at 3 weeks revealed an expected Mendelian frequency.
Figure 2C shows that restriction site for KpnI was present in the
amplicon from the D73N (+/−) mice but not from WT mice.
Because RNAwas isolated from heterozygous D73N (+/−) mice,
the band in the D73N (+/−) mice + KpnI, which lines up with
the other groups, corresponds to the WT allele (since the WT
allele doesn’t have a restriction site for KpnI). The amount of
cTnCD73N transcript in the left ventricle of the D73N (+/−)
mice was estimated at 31 ± 2% of total cTnC transcript. On the
other hand, homozygous mice were born at ∼ half of expected
Mendelian ratio. None of the homozygous D73N (+/+) mice
survived longer than 1 day, suggesting both embryonic and
neonatal lethality.
Effect of the D73N Mutation on the Ca2+
Sensitivity of Force Development in Skinned
Ventricular Trabeculae
Since the D73N mutation desensitized reconstituted thin
filaments to Ca2+, we expected that ventricular trabeculae
isolated from the D73N (+/−) mice would display reduced Ca2+
sensitivity of force development. Figure 3A shows that skinned
ventricular trabeculae isolated from WT mice developed force
with a pCa50 = 5.99± 0.01, while skinned ventricular trabeculae
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FIGURE 2 | Generation of knock-in mice. (A) The gene targeting strategy
to introduce the D73N mutation in cTnC into mouse myocardium. Targeting
vector harbored thymidine kinase (tk) gene, neo cassette flanked by FRT
sites in intron 4, the D73N mutation and two silent substitutions in order to
create a restriction site for the enzyme KpnI in exon 4. Targeting vector was
introduced into ES cells by electroporation. Neo cassette was deleted by
crossing neo (+/−) mice with mice expressing FLP recombinase to create
the D73N (+/−) mice. (B) PCR mediated genotyping of WT, neo (+/−), and
the D73N (+/−) mice. Product lengths are 384, 287, and 517 base pairs for
WT, neo, and D73N alleles, respectively. (C) Undigested and digested
RT-PCR products for WT and the D73N (+/−) mice. KpnI restriction site was
present in the D73N (+/−) mice but not in WT mice. Total RNA was isolated
from the left ventricle of four hearts per genotype, with each KpnI digestion
conducted in triplicate.
isolated from the D73N (+/−) mice developed force with a
pCa50 = 5.76± 0.02, respectively. Thus, our results indicate that
the D73Nmutation led to a statistically significant decrease in the
Ca2+ sensitivity of force development (1pCa50 = −0.23). The
Hill coefficient values were not significantly different between
WT and the D73N (+/−) mice [nH = 4.6 ± 0.3 for WT mice
vs. nH = 5.3 ± 0.3 for the D73N (+/−) mice]. The D73N
mutation did not significantly affect the maximum isometric
force per cross-sectional area generated by the skinned cardiac
trabeculae [Fmax = 16 ± 2 kN/m
2 for WT mice vs. Fmax =
19 ± 3 kN/m2 for D73N (+/−) mice]. Western blot analysis
confirmed that expression levels of total cTnC were not altered
by the D73N mutation (Figure 3B). We also determined that
the D73N mutation did not significantly affect the level of cTnI
phosphorylation at Ser22/23 (Figure 3C).
Effect of the D73N Mutation on Survival, Heart
Weight to Body Weight Ratios, Overall Cardiac
Morphology, and Expression of a Molecular
Marker of Cardiac Hypertrophy
The D73N (+/−) mice were viable, fertile, and displayed no
obvious differences in appearance or activity levels compared to
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FIGURE 3 | Effect of the D73N mutation on the Ca2+ sensitivity of force
development in skinned ventricular trabeculae. (A) Ca2+ dependence of
force development for skinned ventricular trabeculae isolated from 8 ± 0.6
week old WT () or D73N (+/−) (◦) mice. Data represent the mean ± S.E. for
10 trabeculae per genotype (1–2 trabeculae dissected per mouse heart). Data
sets were individually normalized for each genotype and fit with logistic
sigmoid. (B) Western blot analysis of total cTnC expression in the left
ventricular tissue homogenates isolated from 8 ± 0.4 week old mice. The top
panel shows a representative image of a Western blot probed with an antibody
to cTnC or to GAPDH. The bar graphs show the ratio of total cTnC to GAPDH.
Data represent the mean ± S.E. for four hearts per genotype. (C) Western blot
analysis of cTnI phosphorylation in the left ventricular tissue homogenates
isolated from 8 ± 0.4 week old mice. The top panel shows a representative
image of a Western blot probed with an antibody to phosphorylated cTnI or to
total cTnI. The bar graphs show the ratio of phosphorylated cTnI to total cTnI.
Data represent the mean ± S.E. for four hearts per genotype.
WT mice. However, the D73N (+/−) mice began dying at 6
weeks of age and were all dead by 19 weeks of age. Approximately
83% ofmice died suddenly, the rest began exhibiting clear signs of
distress and had to be euthanized. Kaplan-Meier survival analysis
(Figure 4A) showed that median survival age of the D73N (+/−)
mice was ∼12 weeks. Between 4 and 12 weeks, no significant
differences in body weight were observed between WT and the
D73N (+/−) mice (data not shown). However, heart weights
were significantly increased in the D73N (+/−) mice (data not
shown), reflected by increases in heart weight to body weight
ratios between 4 and 12 weeks of age (Figure 4B).
Figure 4C shows representative images of longitudinal
sections of whole mouse hearts stained with H&E at 4, 8 or 12
weeks of age. Analysis of the images revealed a gradual increase
in heart size and dilation of the left ventricular chamber in the
D73N (+/−) mice. At 12 weeks, ∼25% of hearts in the D73N
(+/−) mice displayed left atrial thrombosis (not shown).
RT-PCR analysis was used to evaluate the effect of the D73N
mutation in cTnC on expression of β-MHC and α-MHC in the
left ventricle of 8 week old knock-in mice. Our results show
that transcript levels of β-MHC, a marker of heart failure, were
increased∼2.4-fold in the left ventricle of 8 week old mice, while
transcript levels of α-MHCwere not affected (Figure 4D). Results
of RT-PCR were confirmed by the SDS-PAGE analysis, showing
a statistically significant increase in β-MHC expression in the left
ventricle of 8 week old D73N (+/−) mice at the protein level [β-
MHC= 0.1± 0.1% of total MHC in WTmice vs. β-MHC= 3±
1% of total MHC in D73N (+/−) mice] (gel not shown).
Effect of the D73N Mutation on Cardiac Histology
We wanted to evaluate the effect of the D73N mutation in cTnC
on cardiac histology. Figure 5A shows representative images
of ventricular sections from 12 week old mice, stained with
H&E or Masson’s trichrome. Histological examination of H&E
stained ventricular sections revealed that the D73N mutation led
to ∼35% increase in myocyte cross-sectional area (Figure 5B).
In addition, histological analysis of Masson’s trichrome stained
ventricular sections revealed that the D73N mutation led to a
small but statistically significant increase in myocardial fibrosis
(Figure 5C).
Effect of the D73N Mutation on
Echocardiographic Parameters
The effect of the D73N mutation in cTnC on cardiac
dimensions and contractility of 8 week old mice was evaluated
using echocardiography. Results are shown in Figure 6 and
summarized inTable 2. Echocardiography demonstrated that the
D73N mutation in cTnC did not significantly affect heart rate of
knock-in mice. However, left ventricular posterior wall (LVPW)
thickness in the D73N (+/−) mice was significantly decreased
in systole, while left ventricular anterior wall (LVAW) thickness
in the D73N (+/−) mice was significantly decreased in systole
and diastole. In addition, left ventricular internal dimensions
(LVID) of the D73N (+/−) mice were significantly increased in
both systole and diastole. Furthermore, ejection fraction (EF) and
fractional shortening (FS), measures of cardiac systolic function,
were significantly reduced in the D73N (+/−) mice. Knock-in
mice were able to maintain stroke volume (SV) due to increased
LV dimensions. These results indicate that the Ca2+ desensitizing
mutation in cTnC resulted in hallmark features of DCM in
knock-in mice, namely left ventricular dilation, thinned left
ventricular walls, and impaired systolic function.
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FIGURE 4 | Effect of the D73N mutation on survival, heart weight to
body weight ratios, overall cardiac morphology, and expression of a
molecular marker of cardiac hypertrophy. (A) Kaplan-Meier survival
curves for WT (n = 31) and D73N (+/−) (n = 18) mice. The log-rank test
indicated statistically significant difference between the two curves
(*p < 0.0001). (B) Comparison of heart weight to body weight ratios between
4 ± 0.1, 8 ± 0.4, and 12 ± 0.4 week old WT and D73N (+/−) mice. Data
represent mean ± S.E. for at least seven mice per group. (C) Representative
images of longitudinal heart sections of 4 ± 0.1, 8 ± 0.4, and 12 ± 0.4 week
old WT and D73N (+/−) mice, stained with H&E. Scale bar = 2mm. (D)
RT-PCR analysis of total RNA isolated from the hearts of WT and D73N
(+/−) mice. Total RNA was isolated from the left ventricular myocardium of 8
± 0.4 week old mice and subjected to RT-PCR. The top panel shows
representative images of amplification for β-MHC, α-MHC, or GAPDH
mRNAs, respectively. The bar graphs show the ratio of β-MHC or α-MHC to
GAPDH. Data represent the mean ± S.E. for four hearts per
genotype. *D73N (+/−) values significantly different from their respective WT
values (p < 0.05).
Effect of the D73N Mutation on
Electrocardiographic Parameters
Electrocardiography (ECG) was utilized to assess the effect of the
D73N mutation on the electrical activity of the heart. Figure 7A
shows representative ECG tracings from 8 week old WT and
the D73N (+/−) mice. At 8 weeks, the D73N mutation did
not significantly affect heart rate [HR = 435 ± 7 bpm WT mice
vs. HR = 449 ± 11 bpm in D73N (+/−) mice]. However, the
D73N mutation led to a statistically significant increase in the
QRS complex amplitude between 4 and 12 weeks of age (not
shown), indicative of cardiac hypertrophy in the D73N (+/−)
mice. In addition, the D73Nmutation led to prolongation in QRS
and QT intervals at 4 weeks of age, with further prolongation in
QRS and QT intervals at 8 and 12 weeks of age (Figures 7B,C).
Thus, our results indicate that the D73N mutation led to
electrocardiographic abnormalities in knock-in mice.
Effect of the D73N Mutation on Ca2+ Transients
and Contractility of Ventricular Myocytes
We investigated whether the D73N mutation in cTnC resulted
in altered Ca2+ transients and myocyte contractility. Figure 8
shows the effect of the D73N mutation on the Ca2+ transients
(Figure 8A) and sarcomere shortening (Figure 8B) of Fura-2
loaded isolated ventricular myocytes. Results are summarized in
Table 3. In the absence of ISO stimulation, resting sarcomere
length of myocytes isolated from the D73N (+/−) mice was
significantly longer than that in WT mice, consistent with
reduced myofilament Ca2+ sensitivity in the hearts of the D73N
(+/−) mice. In the absence of ISO stimulation, baseline Ca2+,
the peak height of intracellular Ca2+ transient, departure velocity
(maximal rate of change during Ca2+ release or shortening
phase of the transient) and return velocity (maximal rate of
change during the Ca2+ reuptake or re-lengthening phase of
the transient) of Ca2+ transient/sarcomere shortening, and
fractional sarcomere shortening were not significantly affected
by the D73N mutation. An increase in resting sarcomere length
could lead to an increase in fractional sarcomere shortening
(Mullins and Bondarenko, 2013), compensating for lower
myofilament Ca2+ sensitivity and resulting in normal sarcomere
shortening in myocytes isolated from the D73N (+/−) mice.
Similarly, fractional sarcomere shortening was not reduced in
myocytes isolated from heterozygous knock-in mice harboring
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the DCM-linked 1K210 mutation in cTnT (heterozygous
1K210cTnT mice), despite reduced Ca2+ sensitivity of force
development observed in these mice (Du et al., 2007).
FIGURE 5 | Effect of the D73N mutation on cardiac histology. (A)
Representative microscopic images of left ventricular sections of 12 ± 0.4
week old WT and D73N (+/−) mice, stained with H&E and Masson’s
trichrome. Scale bar = 100µm (B) Bar graphs show values for cross-sectional
area of myocytes from the left ventricular free wall of 12 ± 0.4 week old WT
and D73N (+/−) mice. Data represent the mean ± S.E. for at least 100
nucleated cells per heart from five hearts per genotype. (C) Bar graphs show
the percentage of fibrotic area in the ventricles of 12 ± 0.4 week old WT and
D73N (+/−) mice. Data represent the mean ± S.E. for five hearts per
genotype. *D73N (+/−) values significantly different from their respective WT
values (p < 0.05).
Myocytes isolated from WT mice displayed increases in peak
height of intracellular Ca2+ transient and fractional sarcomere
shortening in response to ISO stimulation. In addition, myocytes
isolated from WT mice exhibited faster departure and return
velocities in response to ISO stimulation. However, myocytes
isolated from the D73N (+/−) mice did not respond to ISO
stimulation. In fact, peak height of intracellular Ca2+ transient
and fractional sarcomere shortening were significantly reduced
in myocytes isolated from the D73N (+/−) mice in the presence
of ISO stimulation compared to that in WT mice. In addition,
departure and return velocities of Ca2+ transient/sarcomere
shortening were significantly slower in myocytes isolated from
the D73N (+/−) mice in the presence of ISO stimulation
compared to that in WT mice. Thus, our results indicate that
the D73N mutation abolished the response to β-adrenergic
stimulation at the cellular level.
Discussion
The objective of this study was to determine whether
desensitizing the regulatory N-domain of cTnC to Ca2+,
TABLE 2 | Effect of the D73N mutation on echocardiographic parameters.
Parameter WT D73N (+/−)
BW (g) 21.2±0.5 21.1± 0.4
HR (bpm) 477±16 449± 26
LVIDd (mm) 3.7±0.2 5.2± 0.1*
LVIDs (mm) 2.3±0.1 4.5± 0.2*
LVAWd (mm) 0.99±0.03 0.85± 0.03*
LVAWs (mm) 1.52±0.06 1.11± 0.04*
LVPWd (mm) 0.82±0.06 0.67± 0.03
LVPWs (mm) 1.27±0.09 0.79± 0.04*
EF (%) 69±2 28± 3*
FS (%) 38±2 13± 2*
SV (µL) 41±4 34± 2
The WT and the D73N (+/−) mice were 8 ± 0.4 weeks old. All values are expressed as
mean ± S.E. (n = 7–8 mice per genotype). BW, body weight; HR, heart rate; LVID, left
ventricular internal dimensions; LVAW, left ventricular anterior wall; LVPW, left ventricular
posterior wall; EF, ejection fraction; FS, fractional shortening; SV, stroke volume; d,
diastole; s, systole. *D73N (+/−) values significantly different from their respective WT
values (p < 0.05).
FIGURE 6 | Effect of the D73N mutation on echocardiographic
parameters. Representative transthoracic echocardiographic M-mode
images of the left ventricle were obtained from 8 ± 0.4 week old WT and
D73N (+/−) mice. Arrows indicate left ventricular internal dimensions in
diastole (LVIDd) and systole (LVIDs). Values for LVIDd and LVIDs are listed in
Table 2.
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FIGURE 7 | Effect of the D73N mutation on electrocardiographic
parameters. (A) Representative ECG tracings from 8 ± 0.4 week old WT
and D73N (+/−) mice. (B) Comparison of QRS intervals between 4 ± 0.1, 8
± 0.4, and 12 ± 0.4 week old WT and D73N (+/−) mice. Data represent
mean ± S.E. for at least 11 mice per group. (C) Comparison of QT intervals
between 4 ± 0.1, 8 ± 0.4, and 12 ± 0.4 week old WT and D73N (+/−)
mice. Data represent mean ± S.E. for at least 11 mice per group. *D73N
(+/−) values significantly different from their respective WT values (p < 0.05).
by accelerating the rate of Ca2+ dissociation, affects the
physiological function of the heart. At sub-saturating levels of
Ca2+, the rate of cardiac muscle contraction is modulated by the
Ca2+ binding properties of cTnC (Norman et al., 2007). Since
the heart primarily functions at sub-saturating levels of Ca2+
(for review Davis and Tikunova, 2008), lower Ca2+ sensitivity
of the regulatory N-domain of cTnC is expected to result in a
decreased number of force-generating cross-bridges recruited
during contraction, leading to systolic dysfunction. Dilation is
expected to occur as a compensatory reaction of the heart to the
weakened cardiac muscle.
Earlier studies showed the importance of acidic residues in
chelating positions of an EF-hand in controlling Ca2+ binding
and exchange with the protein (Procyshyn and Reid, 1994a,b;Wu
and Reid, 1997; Black et al., 2000). In order to decrease the Ca2+
sensitivity of the regulatory N-domain of cTnC, an acidic Asp
residue in the (-X) position of the second Ca2+ binding loop was
substituted with neutral Asn residue, generating cTnCD73N. The
D73N mutation decreased the Ca2+ sensitivity of the regulatory
N-domain of cTnC reconstituted into the thin filament by
increasing the rate of Ca2+ dissociation (Figure 1). The D73N
mutation was then knocked into the endogenous TNNC1
gene via gene targeting technology (Figure 2), generating the
D73N (+/−) mouse model. The advantage of a knock-in
approach is that an endogenous promoter and regulatory
elements are utilized to express the mutant protein, ensuring
expression in the proper tissues (for review Snider and Conway,
2011).
Our results show that trabeculae isolated from the ventricles
of the D73N (+/−) mice displayed a substantial decrease in the
Ca2+ sensitivity of force development compared to WT mice,
without affecting cooperativity or maximum force (Figure 3).
The D73N (+/−) mice were viable and fertile, with no obvious
differences in appearance, body weights or activity levels under
normal mouse husbandry conditions. However, the D73N (+/−)
mice developed hallmark features of early onset DCM, such as:
(1) premature death (Figure 4), (2) increased heart weight to
body weight ratios (Figure 4), (3) small but significant increase
in myocardial fibrosis (Figure 5), (4) increased expression of β-
MHC (Figure 4), (4) increased LVIDwith thinned left ventricular
walls (Figure 6), (5) decreased EF and FS (Figure 6), and (6)
electrophysiological abnormalities (Figure 7).
Diagnostic criteria for DCM in human patients include EF
of less than 45% and/or FS of less than 25% (for review Taylor
et al., 2006). Echocardiographic assessment of D73N (+/−) mice
revealed an average EF of ∼28% and FS of ∼13% (Table 2),
consistent with the diagnosis of DCM. Thus, our results indicate
that the D73N mutation resulted in a substantial impairment of
left ventricular systolic function.
The RT-PCR results revealed a marked increase in β-MHC
transcript level in the left ventricle of the D73N (+/−) mice
compared to that in WT mice (Figure 4). However, SDS-PAGE
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results showed that although there was a significantly greater
amount of β-MHC protein in the left ventricle of the D73N
(+/−) mice, the amount of β-MHC protein relative to the
amount of total MHC was still very low (∼3%). The small shift
in the relative expression of MHC isoforms is unlikely to affect
the Ca2+ sensitivity of force development (Fitzsimons et al., 1998;
Schoffstall et al., 2006; Suzuki et al., 2009).
Most mutations associated with DCM are inherited in an
autosomal dominant pattern (for review Martins et al., 2002;
Towbin, 2014). Affected individuals are usually heterozygous for
any given mutation, and are expected to express the mutant
protein at ∼50% or less. Even a modest amount of mutated
protein can result in severe pathophysiological consequences.
For instance, heterozygous knock-in mice expressing cTnIR21C
[linked to hypertrophic cardiomyopathy (HCM)] at only ∼25%
of total cTnI developed hallmark traits associated with HCM
(Wang et al., 2012). None of the homozygous D73N (+/+)
mice survived longer than one day. The phenotype of the
D73N (+/−) mice resembled that of homozygous knock-in
mice harboring the DCM-linked 1K210 mutation in cTnT
(homozygous 1K210cTnT mice) (Du et al., 2007; Sugihara
et al., 2013). Like the D73N (+/−) mice, homozygous
1K210cTnT mice developed early onset DCM, with decreased
Ca2+ sensitivity of force development, enlarged hearts, left
FIGURE 8 | Effect of the D73N mutation on Ca2+ transients and
contractility of ventricular myocytes. (A) Representative Ca2+ transients
in ventricular myocytes paced at 1Hz, isolated from 8 ± 0.7 week old WT and
D73N (+/−) mice, before and after ISO perfusion. (B) Representative
sarcomere length changes in ventricular myocytes paced at 1Hz, isolated from
8 ± 0.7 week old WT and D73N (+/−) mice, before and after ISO perfusion.
ventricular dilation, and systolic dysfunction. In addition,
electrophysiological abnormalities, such as prolongation of QRS
and QT intervals, were observed in both the D73N (+/−)
(Figure 7) and homozygous 1K210cTnT mice. Prolonged QRS
intervals likely reflect an increase in left ventricular dimensions
and impairment of systolic function (Dhingra et al., 2005) in the
D73N (+/−) mice, while prolonged QT intervals are associated
with increased risk of sudden cardiac death (for review (Schwartz,
2013; Tester and Ackerman, 2014). However, the phenotype of
the D73N (+/−) mice was more severe than that of heterozygous
1K210cTnTmice. Comparison of results obtained in the current
study with that from an earlier study (Liu et al., 2012b) indicates
that the D73N mutation in cTnC had a larger effect on the
Ca2+ sensitivity and rate of Ca2+ dissociation from reconstituted
thin filaments than the 1K210 modification in cTnT. Thus, a
larger extent of Ca2+ desensitization could be responsible for a
more severe phenotype of the D73N (+/−) mice compared to
heterozygous1K210cTnT mice.
In addition to Ca2+ desensitization, the D73N mutation
blunted the effect of cTnI pseudo-phosphorylation on Ca2+
sensitivity and the rate of Ca2+ dissociation from reconstituted
thin filaments (Figure 1). Furthermore, ventricular myocytes
isolated from the D73N (+/−) mice did not respond to β-
adrenergic stimulation (Figure 8). In fact, in the presence of a
β-adrenergic agonist (ISO), myocytes isolated from the D73N
(+/−) mice displayed reduced fractional sarcomere shortening
and slower return and departure velocities, compared to that in
WT mice (Figure 8 and Table 3). Therefore, in the presence of
a β-adrenergic agonist, the D73N mutation resulted in impaired
contractility of ventricular myocytes.
Recently, it was hypothesized that blunting or abolishing the
extent of Ca2+ desensitization (induced by cTnI phosphorylation
during β-adrenergic stimulation) is sufficient to trigger the
development of DCM (for review Messer and Marston, 2014).
In fact, blunting or abolishing of Ca2+ desensitization induced
by cTnI phosphorylation appears to be a common feature
among mutations in cTnC linked to DCM in human patients
(with an exception of the D145E mutation) studied to date
(Biesiadecki et al., 2007; Pinto et al., 2011). In addition,
Ca2+ desensitizing effect of cTnI phosphorylation by PKA was
abolished in skinned muscle fibers isolated from the left ventricle
of homozygous 1K210cTnT mice (Inoue et al., 2013). However,
the “blunting” phenomenon is not unique to DCM, since a
number of HCM-linked mutations also blunt the extent of
Ca2+ desensitization induced by cTnI phosphorylation (Deng
et al., 2003; Schmidtmann et al., 2005). Our results show that
like cTnI pseudo-phosphorylation, the D73N mutation in cTnC
decreased the Ca2+ sensitivity of reconstituted thin filaments by
accelerating the rate of Ca2+ dissociation (Figure 1). Possibly,
the D73N mutation and cTnI phosphorylation each result
in Ca2+ desensitization by destabilizing of the “open” state
of the regulatory N-domain of cTnC reconstituted into thin
filaments, and shifting the equilibrium toward the “closed” state.
Thus, blunted extent of Ca2+ desensitization induced by cTnI
phosphorylation could be a consequence of already decreased
Ca2+ sensitivity in thin filaments reconstituted with the cTnD73N
complex.
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TABLE 3 | Effect of the D73N mutation on Ca2+ transients and sarcomere length shortening measurements.
Parameter WT WT + ISO D73N (+/−) D73N (+/−)+ISO
Ca2+ TRANSIENT MEASUREMENTS
Baseline (R) 0.76±0.03 0.75±0.02 0.71±0.02 0.72± 0.01
Peak height (R) 0.51±0.04 0.71±0.04† 0.48±0.03 0.52± 0.03‡
Time to 50% peak (s) 0.016±0.001 0.0123±0.0004† 0.020±0.002* 0.018± 0.001‡
Time to 75% peak (s) 0.021±0.001 0.0163±0.0005† 0.026±0.002* 0.023± 0.001‡
Time to 50% baseline(s) 0.175±0.008 0.142±0.006† 0.177±0.008 0.164± 0.006‡
Time to 75% baseline (s) 0.29±0.01 0.20±0.01† 0.24±0.01* 0.22± 0.01 6=
Departure velocity (R/s) 31±3 51±4† 28±3 27± 2‡
Return velocity (R/s) −2.7±0.3 −5.6±0.4† −3.4±0.3 −4.0± 0.4‡6=
SARCOMERE LENGTH SHORTENING MEASUREMENTS
Resting SL length (µm) 1.64±0.02 1.64±0.02 1.70±0.01* 1.69± 0.02 6=
Peak height (µm) 0.100±0.009 0.20±0.01† 0.117±0.009 0.12± 0.01‡
Fractional shortening (%) 6.1±0.5 12.3±0.8† 6.9±0.5 7.4± 0.7‡
Time to 50% peak (s) 0.046±0.004 0.038±0.003 0.065±0.003* 0.059± 0.003‡6=
Time to 75% peak (s) 0.071±0.006 0.055±0.005 0.088±0.004* 0.082± 0.004‡
Time to 50% baseline (s) 0.27±0.03 0.22±0.02 0.29±0.01 0.27± 0.01
Time to 75% baseline (s) 0.31±0.03 0.25±0.03 0.33±0.02 0.33± 0.02‡
Departure velocity (µm/s) −2.2±0.3 −4.8±0.5† −1.8±0.2 −2.0± 0.2‡
Return velocity (µm/s) 1.1±0.2 3.0±0.5† 1.0±0.1 1.2± 0.3‡
Ventricular myocytes were isolated from 8 ± 0.7 week old mice. Data values are expressed as mean ± S.E. (n = 14–19 cells isolated from three hearts per genotype). SL, sarcomere
length; R, ratio 340/380. Time to 50% peak, time to 75% peak, time to 50% baseline and time to 75% baseline were measured from time 0. *D73N (+/−) values significantly different
from their respective WT values; † WT + ISO values significantly different from their respective WT values; ‡ D73N (+/−) + ISO values significantly different from their respective WT +
ISO values; 6= D73N (+/−) + ISO values significantly different from their respective WT values. The p-value < 0.05 was considered statistically significant.
The Ca2+ desensitization would lead to hypo-contractile
response at rest, while blunted response to β-adrenergic
stimulation would lead to hypo-contractile response under
stress. Thus, Ca2+ desensitization and blunted response to β-
adrenergic stimulation could both be contributing to the DCM-
like phenotype of D73N (+/−) mice. However, it is likely that
Ca2+ desensitization is primarily responsible for the severity of
the DCM phenotype in the D73N (+/−) mice. For instance,
recently generated transgenic mice, which harbored DCM-linked
mutation E361G in cardiac actin, did not exhibit a DCM-like
phenotype under normal mouse husbandry conditions (Song
et al., 2010). While the E361G mutation in actin abolished the
Ca2+ desensitizing effect of cTnI phosphorylation on cardiac
myofibrils (Memo et al., 2013; Vikhorev et al., 2014), skinned
papillary muscles isolated from the hearts of transgenic mice,
harboring the E361G mutation, did not display a decrease in the
Ca2+ dependence of force development (Song et al., 2010). Thus,
mutations that blunt or abolish the extent of Ca2+ desensitization
induced by cTnI phosphorylation, but don’t desensitize cardiac
muscle to Ca2+, are not likely to result in a phenotype as severe
as occurs in the D73N (+/−) mice.
In conclusion, we generated a novel knock-in mouse model,
enabling us to examine physiological consequences of altering
Ca2+ sensitivity of cTnC. Heterozygous knock-in mice displayed
hallmark features of early onset DCM, such as premature death,
increased left ventricular dimensions with thinned walls, and
impaired systolic function. Our results confirm that abnormal
response of the regulatory N-domain of cTnC to Ca2+ could have
a severe detrimental effect on the normal physiological function
of the heart.
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